Cargando…

The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy

OBJECTIVES: To investigate the effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on macular choroidal thickness parameters in eyes with high-risk proliferative diabetic retinopathy. METHODS: High-risk proliferative diabetic retinopathy patients undergoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Preti, Rony C, Mutti, Anibal, Ferraz, Daniel A, Zacharias, Leandro C, Nakashima, Yoshitaka, Takahashi, Walter Y, Monteiro, Mario L R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314316/
https://www.ncbi.nlm.nih.gov/pubmed/28273240
http://dx.doi.org/10.6061/clinics/2017(02)03
_version_ 1782508496947773440
author Preti, Rony C
Mutti, Anibal
Ferraz, Daniel A
Zacharias, Leandro C
Nakashima, Yoshitaka
Takahashi, Walter Y
Monteiro, Mario L R
author_facet Preti, Rony C
Mutti, Anibal
Ferraz, Daniel A
Zacharias, Leandro C
Nakashima, Yoshitaka
Takahashi, Walter Y
Monteiro, Mario L R
author_sort Preti, Rony C
collection PubMed
description OBJECTIVES: To investigate the effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on macular choroidal thickness parameters in eyes with high-risk proliferative diabetic retinopathy. METHODS: High-risk proliferative diabetic retinopathy patients undergoing laser treatment were prospectively enrolled in this study. One eye was randomly selected for laser treatment combined with bevacizumab injections, study group, whereas the corresponding eye was subjected to laser treatment alone, control group. Spectral-domain optical coherence tomography with enhanced depth imaging was used to measure the macular choroidal thickness prior to and 1 month after treatment. Measurements in both groups were compared. Clinicaltrials.gov: NCT01389505. RESULTS: Nineteen patients (38 eyes) with a mean±standard deviation age of 53.4±9.3 years were evaluated, and choroidal thickness measurements for 15 patients were used for comparison. The greatest measurement before treatment was the subfoveal choroidal thickness (341.68±67.66 μm and 345.79±83.66 μm for the study and control groups, respectively). No significant difference between groups was found in terms of macular choroidal thickness measurements at baseline or after treatment. However, within-group comparisons revealed a significant increase in choroidal thickness parameters in 10 measurements in the study group and in only 5 temporal measurements in the control group when 1-month follow-up measurements were compared to baseline values. CONCLUSIONS: The macular choroidal thickness does not appear to be significantly influenced by laser treatment alone but increases significantly when associated with bevacizumab injections in patients with proliferative diabetic retinopathy and macular edema. Because bevacizumab injections reduce short-term laser pan-retinal photocoagulation-induced macular edema, our findings suggest that the choroid participates in its pathogenesis.
format Online
Article
Text
id pubmed-5314316
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-53143162017-02-17 The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy Preti, Rony C Mutti, Anibal Ferraz, Daniel A Zacharias, Leandro C Nakashima, Yoshitaka Takahashi, Walter Y Monteiro, Mario L R Clinics (Sao Paulo) Clinical Science OBJECTIVES: To investigate the effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on macular choroidal thickness parameters in eyes with high-risk proliferative diabetic retinopathy. METHODS: High-risk proliferative diabetic retinopathy patients undergoing laser treatment were prospectively enrolled in this study. One eye was randomly selected for laser treatment combined with bevacizumab injections, study group, whereas the corresponding eye was subjected to laser treatment alone, control group. Spectral-domain optical coherence tomography with enhanced depth imaging was used to measure the macular choroidal thickness prior to and 1 month after treatment. Measurements in both groups were compared. Clinicaltrials.gov: NCT01389505. RESULTS: Nineteen patients (38 eyes) with a mean±standard deviation age of 53.4±9.3 years were evaluated, and choroidal thickness measurements for 15 patients were used for comparison. The greatest measurement before treatment was the subfoveal choroidal thickness (341.68±67.66 μm and 345.79±83.66 μm for the study and control groups, respectively). No significant difference between groups was found in terms of macular choroidal thickness measurements at baseline or after treatment. However, within-group comparisons revealed a significant increase in choroidal thickness parameters in 10 measurements in the study group and in only 5 temporal measurements in the control group when 1-month follow-up measurements were compared to baseline values. CONCLUSIONS: The macular choroidal thickness does not appear to be significantly influenced by laser treatment alone but increases significantly when associated with bevacizumab injections in patients with proliferative diabetic retinopathy and macular edema. Because bevacizumab injections reduce short-term laser pan-retinal photocoagulation-induced macular edema, our findings suggest that the choroid participates in its pathogenesis. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2017-02 2017-02 /pmc/articles/PMC5314316/ /pubmed/28273240 http://dx.doi.org/10.6061/clinics/2017(02)03 Text en Copyright © 2017 CLINICS http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.
spellingShingle Clinical Science
Preti, Rony C
Mutti, Anibal
Ferraz, Daniel A
Zacharias, Leandro C
Nakashima, Yoshitaka
Takahashi, Walter Y
Monteiro, Mario L R
The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy
title The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy
title_full The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy
title_fullStr The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy
title_full_unstemmed The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy
title_short The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy
title_sort effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the oct-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314316/
https://www.ncbi.nlm.nih.gov/pubmed/28273240
http://dx.doi.org/10.6061/clinics/2017(02)03
work_keys_str_mv AT pretironyc theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy
AT muttianibal theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy
AT ferrazdaniela theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy
AT zachariasleandroc theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy
AT nakashimayoshitaka theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy
AT takahashiwaltery theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy
AT monteiromariolr theeffectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy
AT pretironyc effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy
AT muttianibal effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy
AT ferrazdaniela effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy
AT zachariasleandroc effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy
AT nakashimayoshitaka effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy
AT takahashiwaltery effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy
AT monteiromariolr effectoflaserpanretinalphotocoagulationwithorwithoutintravitrealbevacizumabinjectionsontheoctmeasuredmacularchoroidalthicknessofeyeswithproliferativediabeticretinopathy